BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7585859)

  • 1. Meta-analysis of three trials with quinapril in the treatment of mild-to-moderate hypertension in the Mexican population.
    Alcocer L; Novoa G; Sotres D
    Clin Ther; 1995; 17(3):552-60; discussion 516. PubMed ID: 7585859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Romero R; Castellote E; Ocón J; Wagner B
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
    Lacourcière Y; Lefebvre J; Provencher P; Poirier L
    Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of low-dose hydrochlorothiazide alone or in combination with quinapril in black patients with mild to moderate hypertension.
    Radevski IV; Valtchanova ZP; Candy GP; Hlatswayo MN; Sareli P
    J Clin Pharmacol; 2000 Jul; 40(7):713-21. PubMed ID: 10883412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of low-dose, once-daily quinapril as monotherapy for patients with hypertension.
    Olvera S; Alcocer L; Novoa G
    Clin Ther; 1996; 18(5):864-73. PubMed ID: 8930430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
    Larochelle P
    Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
    Frishman WH; Greenberg S
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of quinapril in the elderly hypertensive patient.
    Forette B; Koen R; Vicaut E
    Am Heart J; 1992 May; 123(5):1426-32. PubMed ID: 1575170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents.
    Canter DA; Texter MJ; McLain RW
    J Hypertens Suppl; 1994; 12(7):S33-8. PubMed ID: 7769502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
    Sánchez S; Luna A; Orozco R; Velasco G
    Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA; Chang SM; Chou TC
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of quinapril therapy on blood pressure and serotonin change in patients with mild to moderate hypertension.
    Huang JL; Cheng FC; Chen YT; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):329-34. PubMed ID: 9037848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM].
    Motero Carrasco J
    Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Lenz T; Schulte KL; Wagner B; Lilienthal J; Gotzen R
    Eur Heart J; 1994 Jul; 15(7):940-6. PubMed ID: 7925516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee].
    Ambrosioni E; Brusca A; Caponnetto S; Condorelli M; Corea L; Dal Palù C; Fogari R; Mameli P; Mancia G; Neri Serneri GG
    Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
    Maclean D
    Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension.
    Heesen WF; Beltman FW; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Meyboom-de Jong B; Lie KI
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):187-94. PubMed ID: 9475259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study.
    Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group.
    Flack JM; Yunis C; Preisser J; Holmes CB; Mensah G; McLean B; Saunders E
    Arch Intern Med; 2000 Jun; 160(12):1842-7. PubMed ID: 10871979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.